Increased involvement of stromal CAFs is a pathophysiological feature associated with both breast and pancreatic ductal adenocarcinoma progression but the role of CAF-FAK in progression of these cancers has not been addressed before. This evidence concerns the gene PTK2 and pancreatic ductal adenocarcinoma.